Reversal of CQ11, a chloroquine derivative, on multidrug resistance in doxorubicin-resistant breast cancer cell line MCF/DOX
- Resource Type
- Authors
- Huan-Zhang Lu; Da-Long Wu; Li-Xin Yin; Feng-Ying Sui; Shirong Ma; Cheng-Wen Zhang
- Source
- The Chinese-German Journal of Clinical Oncology. 7:647-649
- Subject
- Doxorubicin resistant
business.industry
organic chemicals
technology, industry, and agriculture
medicine.disease
carbohydrates (lipids)
Multiple drug resistance
chemistry.chemical_compound
Breast cancer
Oncology
Breast cancer cell line
chemistry
Chloroquine
Surgical oncology
polycyclic compounds
medicine
Cancer research
Doxorubicin
skin and connective tissue diseases
business
Derivative (chemistry)
medicine.drug
- Language
- ISSN
- 1613-9089
1610-1979
Objective To investigate the reversal effect of CQ11, a chloroquine derivative, on multidrug resistance (MDR) in doxorubicin (DOX)-resistant human breast carcinoma cell line MCF/DOX.